Psychiatry and Neurology, Neurology · Milwaukee, WI
NPI
1861447906
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2025 W Oklahoma Ave, Suite 120
Milwaukee, WI, 53215
Phone (414) 382-8960
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
332 services
Medicare patients, 2024
63
Average age 64
Drug cost, 2024
$2.7M
3,305 prescriptions
Company payments, 2025
$5,174
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thulasiraman P Ravichandran was code 99214 (office e&m - established), 135 times for 53 patients. In total Thulasiraman P Ravichandran billed 332 services in 25 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 135 | 53 | $83.04 | $11K |
| 99215 Office E&M - Established | Office | 66 | 47 | $131.62 | $8,687 |
| 70551 MRI/MRA - Head and Neck | Office | 26 | 26 | $50.72 | $1,319 |
By year: 2022 $40K for 399 services; 2023 $30K for 300 services; 2024 $33K for 332 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thulasiraman P Ravichandran prescribed most often to Medicare patients was Pregabalin, with 318 prescriptions and refills. In total Thulasiraman P Ravichandran wrote 3,305 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pregabalin Generic | 318 | 601 | 89 | $14K |
| Briviact Brivaracetam | 215 | 229 | 34 | $333K |
| Lacosamide Generic | 171 | 283 | 37 | $34K |
| Lidocaine Generic | 135 | 139 | 30 | $7,020 |
| Cyclobenzaprine Hcl Generic | 134 | 134 | 31 | $1,084 |
| Xcopri Cenobamate | 131 | 135 | 21 | $197K |
| Diclofenac Sodium Generic | 130 | 132 | 31 | $5,476 |
| Duloxetine Hcl Generic | 125 | 310 | 45 | $3,147 |
| Clopidogrel Clopidogrel Bisulfate | 124 | 318 | 48 | $1,332 |
| Nortriptyline Hcl Generic | 122 | 195 | 28 | $2,303 |
| Gabapentin Generic | 111 | 189 | 25 | $4,021 |
| Rytary Carbidopa/Levodopa | 102 | 163 | 27 | $61K |
| Aptiom Eslicarbazepine Acetate | 98 | 107 | 13 | $249K |
| Levetiracetam Generic | 70 | 131 | 22 | $2,562 |
| Zonisamide Generic | 65 | 146 | 21 | $2,481 |
Brand drugs: - claims; generic drugs: 2,135 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thulasiraman P Ravichandran $5,174 ($5,174 in general payments such as food, travel and fees) from 29 companies. The largest payer was Neurelis, Inc. with $744.
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 60 | $744 |
| Aucta Pharmaceuticals, Inc. | 41 | $628 |
| UCB, Inc. UCB.BR | 30 | $605 |
| SK Life Science, Inc. | 20 | $413 |
| Vanda Pharmaceuticals Inc. VNDA | 22 | $380 |
| Teva Pharmaceuticals USA, Inc. TEVA | 15 | $289 |
| Jazz Pharmaceuticals Inc. JAZZ | 25 | $272 |
| Neurocrine BioSciences, Inc. NBIX | 16 | $232 |
| Amgen Inc. AMGN | 6 | $185 |
| Tonix Medicines, Inc. | 15 | $157 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.